{"id":"W4411284824","doi":"10.1158/1557-3265.sabcs24-ps19-04","title":"Abstract PS19-04: Exploring the broad societal value of pembrolizumab in triple-negative breast cancer in Canada","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Triple-negative breast cancer; Pembrolizumab; Breast cancer; Medicine; Cancer; Value (mathematics); Oncology; Gynecology; Internal medicine; Immunotherapy; Statistics","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004834769,0.0005279377,0.0008793452,0.007521262,0.001608616,0.003659427,0.001204745,0.0006647865,0.003720087],"category_scores_gemma":[0.01796139,0.0002337272,0.002198125,0.01395718,0.0006645917,0.0006648533,0.0008564632,0.0007992267,0.0002404936],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.1106002,"about_ca_system_score_gemma":0.26119,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9864318,"about_ca_topic_score_gemma":0.9916835,"domain_scores_codex":[0.9966093,0.0008128038,0.0002921742,0.0002226905,0.00167596,0.0003870275],"domain_scores_gemma":[0.9862804,0.002992123,0.001048657,0.0001530844,0.008793458,0.00073226],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002674285,0.0004967701,0.1549891,0.1255778,0.007673283,0.002787863,0.003971715,0.02415898,0.002659643,0.03537231,0.1320234,0.5076149],"study_design_scores_gemma":[0.001184816,0.001017468,0.4492489,0.09068094,0.01981562,0.001199803,0.0128424,0.02548136,0.003319463,0.008086972,0.386644,0.0004783512],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"other","genre_scores_codex":[0.2950577,0.3620637,0.004787646,0.04470425,0.0006272785,0.003132892,0.1677767,0.0001742948,0.1216754],"genre_scores_gemma":[0.8347077,0.133193,0.00793446,0.003094518,0.0001314524,0.0006593092,0.01561647,0.00004873075,0.004614309],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.1106002,"threshold_uncertainty_score":0.802464,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1789215425760331,"score_gpt":0.4915326437501494,"score_spread":0.3126111011741163,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}